The Technology Platform

EffRx technology platform allows administering very large pharmaceutical doses and fixed dose combinations thus enhancing patient convenience and adherence. Beyond this, EffRx also focuses on addressing swallowing difficulties in pediatric and geriatric populations, reducing gastrointestinal side effects, as well as other meaningful benefits. Most importantly, the development of such Novel Therapeutic Entities provides opportunity for additional extended Intellectual Property.

The technology platform encompasses effervescent and related formulations that allow the execution of:

  • Novel formulations with new therapeutic advantages, such as
    • faster on-set of action
    • buffering creating better GI environment
    • enhanced or constant absorption profile
    • extended release suspensions
  • Novel fixed dose combinations
  • Novel dosing regimens